Search

Paradigm Biopharmaceuticals

ECM Deals

DateCompanyTransaction TypeTotal Value
18/10/16Paradigm Biopharmaceuticals$6.2m>>

Biography

Paradigm Biopharmaceuticals is a Melbourne-based company that listed on the ASX in August 2015. Paradigm is developing potential orthopaedic and respiratory applications of pentosan polysulphate sodium.
Biography last updated 16 Jan 2017

BNiQ Disclaimer